As of 2025-10-19, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (60.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -73321.4%.
The range of the Relative Valuation is (50.24) - (64.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 22.2x | 19.0x |
| Forward P/E multiples | 17.4x - 28.6x | 23.0x |
| Fair Price | (50.24) - (64.19) | (60.77) |
| Upside | -60629.7% - -77435.8% | -73321.4% |
| Date | P/E |